Revenue: The sum of all revenue fields included for a company's operating activities.
Immuneering Corporation (IMRX) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-61.04M |
|
-- |
|
-- |
|
$64.07M |
|
$-64.07M |
|
$3.03M |
|
$-61.04M |
|
$-61.04M |
|
$-61.04M |
|
$-61.04M |
|
$-61.04M |
|
$-61.04M |
|
$-64.07M |
|
$-63.62M |
|
29.98M |
|
29.98M |
|
$-2.04 |
|
$-2.04 |
|
| Balance Sheet Financials | |
$39.59M |
|
$1.12M |
|
$13.13M |
|
$52.71M |
|
$7.50M |
|
-- |
|
$3.82M |
|
$11.33M |
|
$41.39M |
|
$34.35M |
|
$41.39M |
|
31.05M |
|
| Cash Flow Statement Financials | |
$-55.00M |
|
$26.43M |
|
$5.30M |
|
$59.41M |
|
$36.14M |
|
$-23.26M |
|
$6.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-55.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-147.48% |
|
-177.71% |
|
-115.79% |
|
-147.48% |
|
$1.33 |
|
$-1.84 |
|
$-1.83 |
|